Reported Earnings • Jul 29
First quarter 2027 earnings released: EPS: ₹8.49 (vs ₹14.28 in 1Q 2026) First quarter 2027 results: EPS: ₹8.49 (down from ₹14.28 in 1Q 2026). Revenue: ₹1.79b (up 22% from 1Q 2026). Net income: ₹72.7m (down 41% from 1Q 2026). Profit margin: 4.1% (down from 8.3% in 1Q 2026). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 86% per year but the company’s share price has only increased by 5% per year, which means it is significantly lagging earnings growth. Aankondiging • Jul 29
Mangalam Organics Limited, Annual General Meeting, Sep 24, 2026 Mangalam Organics Limited, Annual General Meeting, Sep 24, 2026, at 15:00 Indian Standard Time. Aankondiging • Jul 23
Mangalam Organics Limited to Report Q1, 2027 Results on Jul 28, 2026 Mangalam Organics Limited announced that they will report Q1, 2027 results on Jul 28, 2026 New Risk • Jul 03
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 9.4% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (2.1x net interest cover). Share price has been highly volatile over the past 3 months (9.4% average weekly change). Earnings have declined by 38% per year over the past 5 years. Minor Risk Market cap is less than US$100m (₹4.58b market cap, or US$48.1m). Valuation Update With 7 Day Price Move • Jun 19
Investor sentiment improves as stock rises 20% After last week's 20% share price gain to ₹563, the stock trades at a trailing P/E ratio of 18.5x. Average trailing P/E is 21x in the Chemicals industry in India. Total returns to shareholders of 34% over the past three years. Valuation Update With 7 Day Price Move • Jun 05
Investor sentiment deteriorates as stock falls 19% After last week's 19% share price decline to ₹469, the stock trades at a trailing P/E ratio of 16.1x. Average trailing P/E is 21x in the Chemicals industry in India. Total returns to shareholders of 13% over the past three years. Reported Earnings • May 31
Full year 2026 earnings released: EPS: ₹29.64 (vs ₹14.71 in FY 2025) Full year 2026 results: EPS: ₹29.64 (up from ₹14.71 in FY 2025). Revenue: ₹6.27b (up 18% from FY 2025). Net income: ₹257.6m (up 105% from FY 2025). Profit margin: 4.1% (up from 2.4% in FY 2025). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 108% per year but the company’s share price has only increased by 10% per year, which means it is significantly lagging earnings growth. Aankondiging • May 25
Mangalam Organics Limited to Report Q4, 2026 Results on May 29, 2026 Mangalam Organics Limited announced that they will report Q4, 2026 results on May 29, 2026 New Risk • May 09
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.4x net interest cover). Earnings have declined by 42% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (8.7% average weekly change). Market cap is less than US$100m (₹5.14b market cap, or US$54.4m). Valuation Update With 7 Day Price Move • May 04
Investor sentiment improves as stock rises 18% After last week's 18% share price gain to ₹537, the stock trades at a trailing P/E ratio of 18.4x. Average trailing P/E is 23x in the Chemicals industry in India. Total returns to shareholders of 15% over the past three years. Reported Earnings • Feb 14
Third quarter 2026 earnings released: EPS: ₹5.07 (vs ₹4.26 in 3Q 2025) Third quarter 2026 results: EPS: ₹5.07 (up from ₹4.26 in 3Q 2025). Revenue: ₹1.64b (up 33% from 3Q 2025). Net income: ₹43.3m (up 19% from 3Q 2025). Profit margin: 2.6% (down from 2.9% in 3Q 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 118% per year but the company’s share price has fallen by 4% per year, which means it is significantly lagging earnings. Aankondiging • Feb 03
Mangalam Organics Limited to Report Q3, 2026 Results on Feb 12, 2026 Mangalam Organics Limited announced that they will report Q3, 2026 results on Feb 12, 2026 New Risk • Jan 07
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 6.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.4x net interest cover). Earnings have declined by 43% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (6.9% average weekly change). Market cap is less than US$100m (₹4.63b market cap, or US$51.6m). Valuation Update With 7 Day Price Move • Nov 19
Investor sentiment deteriorates as stock falls 18% After last week's 18% share price decline to ₹445, the stock trades at a trailing P/E ratio of 16.6x. Average trailing P/E is 25x in the Chemicals industry in India. Total loss to shareholders of 17% over the past three years. Aankondiging • Nov 05
Mangalam Organics Limited to Report Q2, 2026 Results on Nov 14, 2025 Mangalam Organics Limited announced that they will report Q2, 2026 results on Nov 14, 2025 Valuation Update With 7 Day Price Move • Aug 15
Investor sentiment improves as stock rises 22% After last week's 22% share price gain to ₹551, the stock trades at a trailing P/E ratio of 20.9x. Average trailing P/E is 26x in the Chemicals industry in India. Total loss to shareholders of 2.9% over the past three years. Reported Earnings • Aug 09
First quarter 2026 earnings released: EPS: ₹14.28 (vs ₹1.95 in 1Q 2025) First quarter 2026 results: EPS: ₹14.28 (up from ₹1.95 in 1Q 2025). Revenue: ₹1.51b (up 28% from 1Q 2025). Net income: ₹122.3m (up ₹105.6m from 1Q 2025). Profit margin: 8.1% (up from 1.4% in 1Q 2025). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 57% per year but the company’s share price has fallen by 10% per year, which means it is significantly lagging earnings. Aankondiging • Aug 08
Mangalam Organics Limited, Annual General Meeting, Sep 16, 2025 Mangalam Organics Limited, Annual General Meeting, Sep 16, 2025. Aankondiging • Aug 02
Mangalam Organics Limited to Report Q1, 2026 Results on Aug 08, 2025 Mangalam Organics Limited announced that they will report Q1, 2026 results on Aug 08, 2025 Valuation Update With 7 Day Price Move • Jul 21
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to ₹469, the stock trades at a trailing P/E ratio of 31.7x. Average trailing P/E is 30x in the Chemicals industry in India. Total loss to shareholders of 23% over the past three years. Valuation Update With 7 Day Price Move • May 19
Investor sentiment improves as stock rises 38% After last week's 38% share price gain to ₹572, the stock trades at a trailing P/E ratio of 39x. Average trailing P/E is 26x in the Chemicals industry in India. Total loss to shareholders of 17% over the past three years. New Risk • May 14
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 9.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.8x net interest cover). Earnings have declined by 45% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (9.0% average weekly change). Market cap is less than US$100m (₹4.25b market cap, or US$49.9m). Reported Earnings • May 12
Full year 2025 earnings released: EPS: ₹14.60 (vs ₹5.15 in FY 2024) Full year 2025 results: EPS: ₹14.60 (up from ₹5.15 in FY 2024). Revenue: ₹5.30b (up 7.5% from FY 2024). Net income: ₹126.0m (up 186% from FY 2024). Profit margin: 2.4% (up from 0.9% in FY 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 13% per year but the company’s share price has fallen by 20% per year, which means it is performing significantly worse than earnings. Valuation Update With 7 Day Price Move • Feb 21
Investor sentiment improves as stock rises 25% After last week's 25% share price gain to ₹477, the stock trades at a trailing P/E ratio of 41.1x. Average trailing P/E is 25x in the Chemicals industry in India. Total loss to shareholders of 45% over the past three years. Reported Earnings • Feb 08
Third quarter 2025 earnings released: EPS: ₹4.26 (vs ₹1.05 in 3Q 2024) Third quarter 2025 results: EPS: ₹4.26 (up from ₹1.05 in 3Q 2024). Revenue: ₹1.24b (up 12% from 3Q 2024). Net income: ₹36.4m (up 305% from 3Q 2024). Profit margin: 2.9% (up from 0.8% in 3Q 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 39 percentage points per year, which is a significant difference in performance. Aankondiging • Sep 10
Mangalam Organics Limited Appoints Charmi Shah as Company Secretary, Compliance Officer and Nodal Officer of the Company Mangalam Organics Limited announced that based on the recommendation of Nomination and Remuneration Committee, the Board of Directors of the Company, at their Meeting held on September 10, 2024, has considered and approved the appointment of Ms. Charmi Shah as the Company Secretary, Compliance Officer and Nodal Officer of the Company (designated as Key Managerial Personnel) effective September 10, 2024 in terms of the Companies Act, 2013 and Rules framed thereunder and pursuant to Regulation 6 of Listing Regulations. Professional Qualification: Company Secretary and L.L.B. Academic Qualification: B.Com from Mumbai University. Work Experience: Having experience of more than 2 years in the Secretarial and Compliance field. Recent Insider Transactions • Sep 03
Executive Chairman recently bought ₹178m worth of stock On the 2nd of September, Kamal Kumar Dujodwala bought around 320k shares on-market at roughly ₹557 per share. This transaction amounted to 43% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. This was Kamal Kumar's only on-market trade for the last 12 months. Aankondiging • Aug 12
Mangalam Organics Limited, Annual General Meeting, Sep 14, 2024 Mangalam Organics Limited, Annual General Meeting, Sep 14, 2024. Aankondiging • Aug 10
Mangalam Organics Limited Approves the Reconstitution of the Committees Mangalam Organics Limited announce that at its board meeting held on August 10, 2024, on recommendation of the Nomination and Remuneration Committee, the Board of Directors has approved the reconstitution of the following committees, effective from August 10, 2024: Audit Committee Mrs. Manisha Agarwal – Chairperson; Mr. Sanjay Bhiva Kadam – Member; Mr. Kamalkumar Dujodwala – Member. Nomination and Remuneration Committee: Mrs. Manisha Agarwal – Chairperson; Mr. Sanjay Bhiva Kadam – Member; Mr. Kamalkumar Dujodwala – Member. Stakeholder Relationship Committee: Mrs. Manisha Agarwal – Chairperson; Mr. Sanjay Bhiva Kadam – Member; Mr. Kamalkumar Dujodwala – Member. Corporate Social Responsibility Committee: Mrs. Manisha Agarwal – Chairperson; Mr. Sanjay Bhiva Kadam – Member; Mr. Kamalkumar Dujodwala – Member. Reported Earnings • Jul 27
First quarter 2025 earnings released: EPS: ₹1.95 (vs ₹0.36 in 1Q 2024) First quarter 2025 results: EPS: ₹1.95 (up from ₹0.36 in 1Q 2024). Revenue: ₹1.18b (up 8.1% from 1Q 2024). Net income: ₹16.7m (up 446% from 1Q 2024). Profit margin: 1.4% (up from 0.3% in 1Q 2024). The increase in margin was driven by higher revenue. Aankondiging • Jul 18
Mangalam Organics Limited to Report Q1, 2025 Results on Jul 26, 2024 Mangalam Organics Limited announced that they will report Q1, 2025 results on Jul 26, 2024 Aankondiging • Jul 15
Mangalam Organics Limited Announces Resignation of Sharad Kumar Saraf as Independent Director Mangalam Organics Limited announced that Mr. Sharad Kumar Saraf, vide letter dated July 15, 2024 has tendered his resignation as an Independent Director of the Company, with effect from close of business hours on July 15, 2024 due to other professional commitments and pre-occupations. Names of listed entities in which the resigning director holds directorships, indicating the category of directorship and membership of board committees, if any: Technocraft Industries (India) Limited: Managing Director, Member of Stakeholders Relationship Committee, Chairman of Corporate Social Responsibility, Chairman of Risk Management Committee. Aankondiging • Jul 05
Mangalaim Organics Limited (BSE:514418) acquired the remaining 10% stake in Mangalam Pooja Stores Private Limited from Sandeep Shriya for INR 0.1 million Mangalaim Organics Limited (BSE:514418) acquired the remaining 10% stake in Mangalam Pooja Stores Private Limited from Sandeep Shriya for INR 0.1 million on July 4, 2024.Mangalam Organics Limited (BSE:514418) completed the acquisition of the remaining 10% stake in Mangalam Pooja Stores Private Limited from Sandeep Shriya on July 4, 2024. Aankondiging • Jun 13
Mangalam Organics Limited Announces Resignation of Nitin Kore as Company Secretary and Compliance Officer Mangalam Organics Limited announced the resignation of Nitin Kore as Company Secretary and Compliance Officer, with effect from close of business hours of June 12, 2024, For career opportunity. Reported Earnings • Jun 04
Full year 2024 earnings released: EPS: ₹5.02 (vs ₹31.79 loss in FY 2023) Full year 2024 results: EPS: ₹5.02 (up from ₹31.79 loss in FY 2023). Revenue: ₹4.94b (flat on FY 2023). Net income: ₹42.9m (up ₹315.1m from FY 2023). Profit margin: 0.9% (up from net loss in FY 2023). New Risk • May 03
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.4% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.5x net interest cover). Earnings have declined by 35% per year over the past 5 years. Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (8.4% average weekly change). Market cap is less than US$100m (₹3.31b market cap, or US$39.8m). Reported Earnings • Feb 10
Third quarter 2024 earnings released: EPS: ₹1.05 (vs ₹0.57 in 3Q 2023) Third quarter 2024 results: EPS: ₹1.05 (up from ₹0.57 in 3Q 2023). Revenue: ₹1.11b (down 15% from 3Q 2023). Net income: ₹8.99m (up 83% from 3Q 2023). Profit margin: 0.8% (up from 0.4% in 3Q 2023). The increase in margin was driven by lower expenses. New Risk • Nov 11
New major risk - Financial position The company's interest payments are not well covered by earnings. Net interest cover: 1.5x This is considered a major risk. If the company is unable to fund interest repayments on its debt through profits, it may be forced into reducing its debt burden through selling assets, undertaking a potentially costly capital raising or even into bankruptcy in the worst case scenario. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.5x net interest cover). Earnings have declined by 29% per year over the past 5 years. Minor Risks Paying a dividend despite being loss-making. Market cap is less than US$100m (₹3.40b market cap, or US$40.8m). Reported Earnings • Nov 11
Second quarter 2024 earnings released: EPS: ₹0.83 (vs ₹24.99 loss in 2Q 2023) Second quarter 2024 results: EPS: ₹0.83 (up from ₹24.99 loss in 2Q 2023). Revenue: ₹1.69b (up 9.5% from 2Q 2023). Net income: ₹6.31m (up ₹220.3m from 2Q 2023). Profit margin: 0.4% (up from net loss in 2Q 2023). The move to profitability was primarily driven by higher revenue. Reported Earnings • Aug 12
First quarter 2024 earnings released: EPS: ₹0.36 (vs ₹8.05 loss in 1Q 2023) First quarter 2024 results: EPS: ₹0.36 (up from ₹8.05 loss in 1Q 2023). Revenue: ₹1.09b (up 4.5% from 1Q 2023). Net income: ₹3.06m (up ₹72.0m from 1Q 2023). Profit margin: 0.3% (up from net loss in 1Q 2023). The move to profitability was primarily driven by higher revenue. Aankondiging • Aug 12
Mangalam Organics Limited, Annual General Meeting, Sep 29, 2023 Mangalam Organics Limited, Annual General Meeting, Sep 29, 2023. Aankondiging • Aug 04
Mangalam Organics Limited to Report Q1, 2024 Results on Aug 11, 2023 Mangalam Organics Limited announced that they will report Q1, 2024 results on Aug 11, 2023 Reported Earnings • May 28
Full year 2023 earnings released: ₹31.63 loss per share (vs ₹62.75 profit in FY 2022) Full year 2023 results: ₹31.63 loss per share (down from ₹62.75 profit in FY 2022). Revenue: ₹4.93b (flat on FY 2022). Net loss: ₹272.2m (down 151% from profit in FY 2022). Aankondiging • May 19
Mangalam Organics Limited to Report Fiscal Year 2023 Results on May 26, 2023 Mangalam Organics Limited announced that they will report fiscal year 2023 results on May 26, 2023 Reported Earnings • Jan 29
Third quarter 2023 earnings released: EPS: ₹0.57 (vs ₹17.66 in 3Q 2022) Third quarter 2023 results: EPS: ₹0.57 (down from ₹17.66 in 3Q 2022). Revenue: ₹1.30b (up 11% from 3Q 2022). Net income: ₹4.92m (down 97% from 3Q 2022). Profit margin: 0.4% (down from 13% in 3Q 2022). The decrease in margin was driven by higher expenses. Aankondiging • Jan 20
Mangalam Organics Limited to Report Q3, 2023 Results on Jan 27, 2023 Mangalam Organics Limited announced that they will report Q3, 2023 results on Jan 27, 2023 Aankondiging • Jan 12
Mangalam Organics Limited Announces Director Appointments Mangalam Organics Limited approved appointment of Mr. Sanjay Bhiva Kadam (DIN:09826377), as an Independent Director of the Company and the appointment of Mr. Sidharath Singh Sekhon, (DIN: 01983046), as an Independent Director of the Company. Valuation Update With 7 Day Price Move • Nov 07
Investor sentiment improved over the past week After last week's 16% share price gain to ₹622, the stock trades at a trailing P/E ratio of 16.8x. Average trailing P/E is 19x in the Chemicals industry in India. Total loss to shareholders of 43% over the past year. Reported Earnings • Aug 15
First quarter 2023 earnings released: ₹8.05 loss per share (vs ₹17.50 profit in 1Q 2022) First quarter 2023 results: ₹8.05 loss per share (down from ₹17.50 profit in 1Q 2022). Revenue: ₹1.05b (down 1.0% from 1Q 2022). Net loss: ₹68.9m (down 146% from profit in 1Q 2022). Valuation Update With 7 Day Price Move • Jun 20
Investor sentiment deteriorated over the past week After last week's 17% share price decline to ₹539, the stock trades at a trailing P/E ratio of 9.2x. Average trailing P/E is 16x in the Chemicals industry in India. Reported Earnings • May 30
Full year 2022 earnings released: EPS: ₹62.68 (vs ₹99.11 in FY 2021) Full year 2022 results: EPS: ₹62.68 (down from ₹99.11 in FY 2021). Revenue: ₹4.92b (up 46% from FY 2021). Net income: ₹537.4m (down 37% from FY 2021). Profit margin: 11% (down from 25% in FY 2021). The decrease in margin was driven by higher expenses. Valuation Update With 7 Day Price Move • Feb 18
Investor sentiment deteriorated over the past week After last week's 18% share price decline to ₹876, the stock trades at a trailing P/E ratio of 8.8x. Average trailing P/E is 20x in the Chemicals industry in India. Reported Earnings • Feb 13
Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations Third quarter 2022 results: EPS: ₹17.66 (down from ₹34.65 in 3Q 2021). Revenue: ₹1.18b (up 9.1% from 3Q 2021). Net income: ₹151.2m (down 49% from 3Q 2021). Profit margin: 13% (down from 28% in 3Q 2021). The decrease in margin was driven by higher expenses. Revenue was in line with analyst estimates. 
